SBRT for Prostate Cancer
rule

SBRT for Organ-Confined Prostate Cancer
MEDICAL PHYSICIST


A session from the 2016 RSS Webinar Series as presented by:

  • Alan Katz, MD, JD, Flushing Radiation Oncology Services, NY

This course is available from April 7, 2016 through 11:59 p.m. Eastern time on April 7, 2019. In order to earn credit for this course, participants must:

    • View the audio/slide presentation
    • Pass the five-question examination with a minimum of 70 percent, and
    • Complete the course evaluation.

The activity is approximately 1 hour in length.


STATEMENT OF NEED

Prostate cancer remains the most commonly diagnosed cancer, other than skin cancer, in men in the US, and is the second leading cause of cancer-related deaths in American men. The majority of prostate cancers are diagnosed at an early-stage, where treatment options including surgery, brachytherapy, external beam radiation therapy and active surveillance, all result in excellent local control and survival rates. Each of these treatment options have different urinary, bowel and sexual function side effects and treatment choice is often determined by evaluation of the toxicity profiles associated with the treatment.

Stereotactic body radiotherapy (SBRT), the ability to deliver high doses of radiation in a small number of fractions, is a relatively new (less than 10 years follow-up) treatment option for organ-confined prostate cancer, however studies from several institutions have shown excellent local control with minimal urinary, bowel and sexual function toxicities. Radiobiological studies also suggest an advantage of delivering high doses of radiation per fraction to treat prostate cancer. There is growing interest for the use of SBRT for the treatment of organ-confined prostate and a need to educate healthcare professionals on the rationale, growing body of published reports, treatment techniques, clinical outcomes , toxicity and quality of life after SBRT treatment of organ-confined prostate cancer. This webinar presented by Dr. Alan Katz, a leader in the field of prostate SBRT, will be discussing his 9-year experience treating prostate cancer patients with SBRT, including treatment techniques, clinical outcomes, toxicity and quality of life.


TARGET AUDIENCE

This program is designed to meet the needs of radiation oncologists and physicists with interests in the early prostate SBRT.


 ACTIVITY OBJECTIVES

  1. Identify candidates for SBRT for prostate cancer
  2. Ability to describe the proper methods for CTV delineation for intact spinal metastases.
  3. Identify optimal dose

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AMEDCO and the Radiosurgery Society® (RSS). AMEDCO is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

AMEDCO designates this live activity for a maximum of 1 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The Radiosurgery Society Self-Assessment Module (SAM) titled SBRT for Organ-Confined Prostate Cancer is qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. This MP SAM is "Qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has qualified for 1 SAM credit." The ABR qualified this MP SAM on April 7, 2016.


COURSE FEES

  • Non-Member: $10.00
  • RSS Member: Free (login to find the discount code)


TECHNOLOGY REQUIREMENTS

Software Requirements

  • A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher

A note on browser incompatibility:

  • We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
  • Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
  • Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot. http://get.adobe.com/flashplayer/

Hardware Requirements

  • Windows Based Computer, Mac based Computers, smart phone, tablets
  • Windows XP SP 3 or Vista Home Premium or better
  • Mac OS x 10.5.3 or better
  • Pentium 4 or better
  • 1meg of System Ram (Memory)
  • True Color 32 bit video card
  • Soundcard and speakers

For more help with technical issues please click here.

POLICIES

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.

Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.

Please contact admin@therss.org if you have questions.

Member login  
rule

ABSTRACT SUBMISSION DEADLINE
Saturday, April 1, 2017



   
the RSS would like to
acknowledge and thank our 
Corporate Sponsors.

    

the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice
Sponsors.






  
the RSS is pleased to collaborate with the following:







Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype
divider